Contact
Please use this form to send email to PR contact of this press release:
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
TO:
Please use this form to send email to PR contact of this press release:
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
TO: